A new promising influential area in modern biology and medicine is ribonucleic acid (RNA) biology. It has revolutionised molecular biology and will have profound implication for future therapies.
The Instituto de Medicina Molecular João Lobo Antunes (iMM) in Portugal will gain the support it needs to achieve scientific excellence and promote research in RNA biology. The EU-funded project RiboMed will help iMM establish a strategic collaboration via twinning with partners from already well recognised communities working on RNA biology in the University of Oxford (UK), the Weizmann Institute of Science (Israel) and The Max Delbrück Center for Molecular Medicine (MDC, Germany).
Know more about RiboMed here.